Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jonathan Silverstein currently holds 4,267,564 shares of INTERCEPT PHARMACEUTICALS INC (ICPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jonathan Silverstein has been a net seller of ICPT stock. They have purchased $47.8M and sold $315.9M worth of shares.
Jonathan Silverstein's most recent insider trade was on Oct 2, 2020, when they purchased 200,000 shares at $25.00 per share.
Jonathan Silverstein serves as Executive at INTERCEPT PHARMACEUTICALS INC (ICPT). They have executed 178 insider transactions totaling $363.7M over their tenure at the company.
Jonathan Silverstein holds the position of Executive at INTERCEPT PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Jonathan Silverstein has shown a selling trading pattern, with $47.8M in total purchases and $315.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jonathan Silverstein was on Aug 17, 2017, when they sold $8.5M worth of GKOS shares. This transaction involved 224,780 shares at $37.85 per share.
Jonathan Silverstein currently owns 4,267,564 shares of INTERCEPT PHARMACEUTICALS INC (ICPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jonathan Silverstein's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jonathan Silverstein has 178 Form 4 filings on record as an insider at INTERCEPT PHARMACEUTICALS INC.
Set alerts for Jonathan Silverstein and 40,000+ other insiders.